Manulife (Manufacturers Life Insurance)’s PDS Biotechnology PDSB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-12,134
Closed -$48.1K 3029
2024
Q1
$48.1K Hold
12,134
﹤0.01% 2887
2023
Q4
$60.3K Hold
12,134
﹤0.01% 2907
2023
Q3
$61.3K Hold
12,134
﹤0.01% 2926
2023
Q2
$61K Buy
+12,134
New +$79.5K ﹤0.01% 2942
2018
Q3
Sell
-51
Closed -$1K 3605
2018
Q2
$1K Sell
51
-766
-94% -$16K ﹤0.01% 4257
2018
Q1
$19K Sell
817
-108
-12% -$29K ﹤0.01% 3763
2017
Q4
$173K Buy
925
+31
+3% +$6.24K ﹤0.01% 3112
2017
Q3
$192K Sell
894
-12
-1% -$2.48K ﹤0.01% 3008
2017
Q2
$186K Buy
906
+188
+26% +$37K ﹤0.01% 3080
2017
Q1
$131K Buy
718
+82
+13% +$16.2K ﹤0.01% 3065
2016
Q4
$159K Buy
636
+13
+2% +$2.95K ﹤0.01% 2965
2016
Q3
$130K Sell
623
-20
-3% -$3.96K ﹤0.01% 3072
2016
Q2
$130K Buy
643
+441
+218% +$78K ﹤0.01% 3058
2016
Q1
$38K Buy
+202
New +$36.1K ﹤0.01% 3355

Other funds holding PDSB

Manulife (Manufacturers Life Insurance)'s PDSB Position: Q2 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of PDS Biotechnology (PDSB) in Q2 2024, closing a stake of 12,134 shares — an estimated $48.1K sold.

Manulife (Manufacturers Life Insurance) first reported a position in PDSB in Q1 2016 and held it in 14 quarters. The position peaked at $192K in Q3 2017. 77 funds tracked by Wall St. Rank hold PDSB as of Q2 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining PDS Biotechnology position as of Q2 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 12,134 PDS Biotechnology shares in Q2 2024, an estimated $48.1K.
  • Manulife (Manufacturers Life Insurance) first reported a position in PDS Biotechnology in Q1 2016 and held it in 14 quarters.
  • Manulife (Manufacturers Life Insurance)'s PDS Biotechnology position peaked at $192K in Q3 2017.
  • 77 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2024, filed 14 Aug 2024.